Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Horak

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|October 5, 1993
Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lynI Stefanová, M L Corcoran, E M Horak, et al.
Leukemia|April 9, 2005
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibodyR M Sharkey, H Karacay, C-H Chang, et al.
Journal of Medicinal Chemistry|October 1, 1993
Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitorsM S Smyth, I Stefanova, F Hartmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1991
T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lckI D Horak, R E Gress, P J Lucas, et al.
Journal of Medicinal Chemistry|February 19, 1993
Bicyclic compounds as ring-constrained inhibitors of protein-tyrosine kinase p56lckT R Burke, B Lim, V E Marquez, et al.
Nature|December 6, 1990
No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120I D Horak, M Popovic, E M Horak, et al.
Mutation Research|August 8, 1996
Gene-specific repair in human CD4+ lymphocytes reflects transcription and proliferationZ Bartośova, M Pirśel, W Reinhold, et al.
Gene Therapy|December 24, 2010
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfectionY Zhang, Z Qu, S Kim, et al.
International Journal of Cancer|January 17, 1997
Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell linesF Hartmann, E M Horak, C Cho, et al.
Journal of the National Cancer Institute|February 26, 1999
Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancerH I Scher, W M Kelly, Z F Zhang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|October 5, 1993
Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lynI Stefanová, M L Corcoran, E M Horak, et al.
Leukemia|April 9, 2005
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibodyR M Sharkey, H Karacay, C-H Chang, et al.
Journal of Medicinal Chemistry|October 1, 1993
Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitorsM S Smyth, I Stefanova, F Hartmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1991
T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lckI D Horak, R E Gress, P J Lucas, et al.
Journal of Medicinal Chemistry|February 19, 1993
Bicyclic compounds as ring-constrained inhibitors of protein-tyrosine kinase p56lckT R Burke, B Lim, V E Marquez, et al.
Nature|December 6, 1990
No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120I D Horak, M Popovic, E M Horak, et al.
Mutation Research|August 8, 1996
Gene-specific repair in human CD4+ lymphocytes reflects transcription and proliferationZ Bartośova, M Pirśel, W Reinhold, et al.
Gene Therapy|December 24, 2010
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfectionY Zhang, Z Qu, S Kim, et al.
International Journal of Cancer|January 17, 1997
Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell linesF Hartmann, E M Horak, C Cho, et al.
Journal of the National Cancer Institute|February 26, 1999
Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancerH I Scher, W M Kelly, Z F Zhang, et al.
Pageof 3